Title:
CRYSTAL FORM OF PYRIMIDINE SULFONAMIDE COMPOUND AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/233694
Kind Code:
A1
Abstract:
Disclosed are a crystal form (I) of a pyrimidine sulfonamide compound and a preparation method therefor. The present invention relates to an application thereof in the preparation of a medicament for treating diseases related to ETA receptor antagonists.
More Like This:
| WO/2012/083048 | ANTI-VIRAL COMPOUNDS |
| JP4277576 | Organic electroluminescence elements, lighting devices and display devices |
| JP2020502136 | Bisarylamide as an NRF2 regulator |
Inventors:
LI JUNMIAO (CN)
LEI MAOYI (CN)
LUO YUNFU (CN)
LEI MAOYI (CN)
LUO YUNFU (CN)
Application Number:
PCT/CN2020/091737
Publication Date:
November 26, 2020
Filing Date:
May 22, 2020
Export Citation:
Assignee:
SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD (CN)
International Classes:
C07D401/14; A61K31/506; A61P9/12; C07D405/14; C07D407/14; C07D409/14
Domestic Patent References:
| WO2019101039A1 | 2019-05-31 | |||
| WO2002053557A1 | 2002-07-11 | |||
| WO2002005355A1 | 2002-01-17 |
Foreign References:
| CN109232546A | 2019-01-18 |
Other References:
"Chinese Pharmacopoeia", vol. IV, 2015, article "General Principles", pages: 9001
See also references of EP 3974421A4
See also references of EP 3974421A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: